Brian Daniels BS, MS, MD Age 67 Independent Non-executive Director Director of CSL Limited since December 2024. Carolyn Hewson AO BEc (Hons), MA Age 70 Independent Non-executive Director Director of CSL Limited since December 2019. Samantha Lewis BA (Hons), CA Age 56 Independent Non-executive Director Director of CSL Limited since January 2024. Dr Daniels has over 30 years’ experience in clinical development, medical affairs, commercialisation and biotech investing. Dr Daniels is currently a partner at 5AM Ventures, joining as a Venture Partner in 2014 and becoming a Partner in 2018. Dr Daniels spent more than 20 years in clinical drug development, including leading the Development and Medical Affairs division at Bristol-Myers Squibb. He directed the development of numerous innovative medicines across a number of therapeutic areas including in Cardio-Vascular, Virology and Oncology. Dr Daniels received Bachelor of Science and Medical Science degrees from Massachusetts Institute of Technology and his MD from Washington University, St Louis. He trained in internal medicine at New York Hospital and rheumatology/ immunology at UCSF. Other directorships and offices (current and recent): • Chairperson Artiva Biotherapeutics (since June 2020); and • Director Inipharm (since October 2020). Board Committee memberships: • Member of the Innovation and Development Committee. Ms Lewis is an experienced non-executive director serving on boards of ASX 100 companies since 2014. Ms Lewis is a chartered accountant with extensive experience in accounting, finance, auditing, risk management, corporate governance, capital markets and due diligence. Prior to becoming a Non-executive Director at CSL, Ms Lewis was a partner at Deloitte. In that role, she acted as lead auditor of a number of major Australian listed entities and provided accounting and transactional advisory services including due diligence, IPOs and debt/equity raisings. Ms Lewis has significant experience working with companies in the manufacturing, retail and industrial sectors. Other directorships and offices (current and recent): • Director of APA Group Limited (since October 2024); • Director of Australia Pacific Airports Corporation Limited (since October 2022); • Former Director of Nine Entertainment Co. Holdings Limited (from March 2017 to June 2025); and • Former Director of Orora Limited (from March 2014 to April 2024). Board Committee memberships: • Member of the Audit and Risk Management Committee. Ms Hewson is a former investment banker with over 35 years’ experience in the finance sector. She was previously an executive director of Schroders Australia Limited and has extensive financial markets, risk management and investment management expertise. She has long-term non-executive experience in a number of sectors bringing a breadth of experience and insight on strategy, capital management and portfolio optimisation through cycles, financial and non-financial risk, social value, organisational culture and the changing external environment. In 2009, Ms Hewson was made an Officer in the Order of Australia for her services to the broader community and to business. Other directorships and offices (current and recent): • Member of the Reserve Bank Monetary Policy Board (since March 2025) and formerly a member of the Reserve Bank Board (since April 2021); and • Former Director of Infrastructure SA (from January 2019 to February 2025). Board Committee memberships: • Chair of the Corporate Governance and Nomination Committee; • Member of the Audit and Risk Management Committee; and • Member of the Human Resources and Remuneration Committee. 43 CSL Limited Annual Report 2025/26
RkJQdWJsaXNoZXIy MjE2NDg3